Article
Document
Anualidad
Academic Article
Information Content Entity
Continuant
Entity
Generically Dependent Continuant
STAT3-targeted treatment with silibinin overcomes the acquired resistance to crizotinib in ALK-rearranged lung cancer
RDF description of STAT3-targeted treatment with silibinin overcomes the acquired resistance to crizotinib in ALK-rearranged lung cancer - http://research.umh.es/vivo/pub/articulo/169509